Patients' perceptions on informed consent and the quality of information disclosure in clinical trials

https://doi.org/10.1016/0738-3991(96)00859-2Get rights and content

Abstract

In a survey on 26 clinical trials we studied how patients experience and evaluate the information disclosure on the clinical trial they are enrolled in and which factors influence patients' perceptions of information disclosure. Our objective was to obtain more insight thereby in how informed consent is applied in the daily practice of clinical trials. Interviews were held with 198 adult patients and 32 trial-clinicians. Instead of focusing on patient comprehension of the information disclosed we analyzed patient perceptions of informed consent. Patients proved to be quite satisfied with the oral and written information disclosure. Patients' perceptions of the manner and content of information disclosure are influenced by more general attitudes towards medical care, research and institutions. Patients' trust in medical experiments, belief in the integrity of physicians and interest in medical affairs have an impact on the way patients perceive information disclosure. To improve the quality of the informed consent procedure, we propose a patient motivation classification (PMC) to enable trial-clinicians to gain more insight into patient motivation. Relevant factors found in our data have been used as criteria for classification. An informed decision making checklist (IDC) is suggested for patients as a general outline for patient education, covering relevant socio-psychological factors of enrolment.

References (13)

  • R Simes et al.

    Randomised comparison of informed consent in clinical trials of treatment for cancer

    Br Med J

    (1986)
  • L Morris et al.

    Impact of risk communication on accrual, regimen, and follow up compliance

  • P Appelbaum et al.

    Informed consent: legal theory and clinical practice

    (1987)
  • L Lesko et al.

    Patients', parents' and oncologists' perception of informed consent for bone marrow transplantation

    Med Paediatr Oncol

    (1989)
  • F Verheggen et al.

    Determinants of patient participation in clinical trials in the context of informed consent: why patients enter a clinical trial or not

    (1995)
  • J Ware et al.

    Patient assessments of their care

There are more references available in the full text version of this article.

Cited by (64)

  • Altruism: Scoping review of the literature and future directions for HIV cure-related research

    2020, Journal of Virus Eradication
    Citation Excerpt :

    It may be motivated by social conditions, such as natural disasters, war and genocide,24,25 by socio-political factors, such as social class and entrenched ideology, and by established relationships with particular individuals or social identity groups, such as parents or religious communities.26,27 Altruism is a key motivating factor for participation in clinical research but is often suffused with the desire for personal benefit.3,28–32 Altruism may also be tied to research design factors, such as the trial design itself, presentation of safety information,33 quality of life, and financial issues.34

  • Determinants of informed consent in a cataract surgery clinical trial: Why patients participate

    2012, Canadian Journal of Ophthalmology
    Citation Excerpt :

    The variables measured in the questionnaire concerning general health perceptions and patients' self-defined medical histories are relevant to explaining patients' perceptions of disclosure of information. In addition, general attitudes, evaluations, and values concerning medical care, research, and institutions are expected to explain patients' perceptions of risks, discomforts, and benefits.3,9 Concepts related to patients' expectations, attitudes, and perceptions were studied by using close-ended multiple questions with Likert-scale items (responses graded from 1 to 4, 4 being the most important).13

  • Healthy Women's Motivators and Barriers to Participation in a Breast Cancer Cohort Study: A Qualitative Study

    2009, Annals of Epidemiology
    Citation Excerpt :

    Nonetheless, it was clear from the MMHS respondent focus groups that complete comprehension of the study did not factor greatly into MMHS respondents’ decisions to participate. There was very little difference in detailed knowledge about the study between the respondent and non-respondent groups, which corresponds with other studies examining participant and non-participant study understanding (30). Lack of study understanding is problematic in the context of informed consent.

  • Personal physicians as study investigators: Impact on patients' willingness to participate in clinical trials

    2009, Contemporary Clinical Trials
    Citation Excerpt :

    Increased use of personal physicians as study investigators poses a number of benefits that extend beyond the issue of expedited recruitment. Many patients fail to read informed consent forms thoroughly, thus placing a premium on verbal information from a clinician to inform the patient's evaluation of potential risk and benefit [10]. Using a patient's personal physician for consent capitalizes on communication that is already established and central to the patient–provider relationship.

View all citing articles on Scopus
View full text